Kotelis Drosos, Bischoff Moritz S, Rengier Fabian, Ruhparwar Arjang, Gorenflo Matthias, Böckler Dittmar
Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.
Interact Cardiovasc Thorac Surg. 2016 Jan;22(1):26-31. doi: 10.1093/icvts/ivv297. Epub 2015 Oct 26.
To analyse early and long-term results of thoracic endovascular aortic repair (TEVAR) in patients with pseudoaneurysms after open aortic coarctation (CoA) repair.
A total of 11 patients of 418 patients who had been treated with TEVAR during the period from January 1998 to April 2015 (8 males; median age 53 years) were retrospectively analysed. Dacron patch aortoplasty was primarily performed in 9 patients and subclavian flap aortoplasty in 2 patients. Seven of the 11 patients had asymptomatic pseudoaneurysms (median diameter 56 mm, range 20-65 mm) diagnosed by routine screening. Symptomatic patients presented with haemoptysis, lower limb ischaemia, haemodynamic collapse and back pain and underwent emergency repair (4/11). Adjunctive procedures at the proximal landing zone were required in 7/11 patients. The median number of implanted endoprostheses per patient was 1 (range: 1-5). The median follow-up was 60 months (range 6-161 months).
Technical success was achieved in 91% (10/11; 1 secondary elective open conversion). The 30-day mortality was 0%. The stroke rate was 18% (2 non-disabling strokes). In 2 patients (20%), stent-graft displacement during deployment was observed. The reintervention rate was 33% (Type Ib endoleak, left arm claudication, partial coverage of the left common carotid artery). Clinical success during follow-up was achieved in 10/11 patients. In 9/10 patients, aneurysm sac shrinkage was observed. The Type II endoleak rate was 10% (1/10; intercostal artery). The overall mortality rate was 9% (1 patient died of amyotrophic lateral sclerosis).
Endovascular treatment of post-coarctation pseudoaneurysms is feasible in elective and emergency cases, yielding durable results in the long term. Due to anatomical specifics, implantation may be challenging and requires careful procedural planning. On-site cardiothoracic surgery backup is essential in case open conversion is required.
分析胸主动脉腔内修复术(TEVAR)治疗开放性主动脉缩窄(CoA)修复术后假性动脉瘤患者的早期和长期结果。
回顾性分析1998年1月至2015年4月期间接受TEVAR治疗的418例患者中的11例(8例男性;中位年龄53岁)。9例患者主要行涤纶补片主动脉成形术,2例患者行锁骨下皮瓣主动脉成形术。11例患者中有7例通过常规筛查诊断为无症状假性动脉瘤(中位直径56mm,范围20 - 65mm)。有症状的患者表现为咯血、下肢缺血、血流动力学衰竭和背痛,并接受了急诊修复(4/11)。11例患者中有7例需要在近端锚定区进行辅助手术。每位患者植入的血管内假体中位数为1个(范围:1 - 5个)。中位随访时间为60个月(范围6 - 161个月)。
技术成功率为91%(10/11;一次二次选择性开放转换)。30天死亡率为0%。卒中发生率为18%(两次非致残性卒中)。2例患者(20%)在植入过程中观察到支架移植物移位。再次干预率为33%(Ib型内漏、左臂间歇性跛行、左颈总动脉部分覆盖)。11例患者中有10例在随访期间获得临床成功。10例患者中有9例观察到动脉瘤囊缩小。II型内漏发生率为10%(1/10;肋间动脉)。总死亡率为9%(1例患者死于肌萎缩侧索硬化症)。
血管内治疗缩窄术后假性动脉瘤在择期和急诊病例中是可行的,长期效果持久。由于解剖学特点,植入可能具有挑战性,需要仔细的手术规划。如有开放转换的需要,现场心胸外科后备至关重要。